PNC-27
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Objectives. Paclitaxel is widely used in the treatment of gynecologic malignancies. It targets tumor cells in the M phase of the…
OBJECTIVE
Despite an 80% response rate to chemotherapy, epithelial ovarian cancer has the highest case fatality rate of all…
PurposePNC-27, a peptide that contains an HDM-2-binding domain from p53 attached to a membrane-penetrating peptide on its…
The anticancer peptide PNC-27, which contains an HDM-2-binding domain corresponding to residues 12-26 of p53 and a transmembrane…
In vivo and in vitro studies have shown the efficiency of anti-cancer peptides PNC-27 and PNC-28 in killing cancer cells by…
LB-195 We have previously shown that two novel peptides, PNC-27 and PNC-28, that contain p53 hdm2 binding domain sequences 12-26…
PNC-27, a synthetic peptide, is derived from the TP53-HDM2 binding domain that include TP53 amino acids 12-26 linked with 17…
We have recently found that a peptide from the mdm-2 binding domain of the p53 protein induced rapid membranolytic necrosis of a…